Lyft already provides transportation services for patients at certain US hospitals seeking non-urgent treatment, but this new service is a first-of-its-kind partnership and one, according to both companies, that could conceivably solve one of the biggest problems related to conducting and maintaining clinical trials: access to transport.
“We believe that this service will make enrolling and staying in a study easier, especially for those patients with limited resources and access to transportation,” said Nariman Nasser, vice president of site optimisation at Continuum Clinical. The first trial that will test the new partnership will be conducted within the next two months and will be focused on a national study for lupus. The combination of a mobility service with a digital, automated scheduling element will ensure that patients taking part will arrive and leave on time, however intense or dispersed the trial.